Last reviewed · How we verify

NCT04063436

Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Withdrawn NA Last updated 23 March 2020
What this trial tests

NA trial testing New nasal pillows mask with PAP therapy in Obstructive Sleep Apnea. Withdrawn.

Timeline
23 September 2019
Primary endpoint
11 October 2019
11 October 2019

Quick facts

Lead sponsorFisher and Paykel Healthcare
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date23 September 2019
Primary completion11 October 2019
Estimated completion11 October 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Fisher and Paykel Healthcare — full company profile →

Who can join

22 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is designed to evaluate the performance, comfort, and usability of a new nasal pillows mask for the treatment of obstructive sleep apnea (OSA) in a home environment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other Fisher and Paykel Healthcare trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04063436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing